Structure-Based Drug Design

Rational design of molecules targeting ion channels has been severely limited by the lack of solved high-resolution structures. TetraGenetics is now in the unique position to combine TetraExpress™ produced ion channels with the power of cryoEM to determine high-resolution structures. In collaboration with leaders of ion channel biology TetraGenetics is creating a new paradigm for ion channel structure-based drug discovery.